Fully-developed technology for the manufacture of recombinant human granulocyte colony stimulating factor (G-CSF).

• High yielding process.
• Quality matching branded product.
• E. coli based expression.
• Product registered in the Indian market.
• Clinically well proven.
• Unlimited supplies available for bulk and finished product in pre-filled syringes.
• Complete product dossier available for registration.

 Patent Number: 1336/MUM/2007

Patent Title :Process for the preparation of granulocyte colony-stimulating factor

Out-licensing of technology for recombinant G-CSF derived from E. coli * Registration of rHu G-CSF in non-regulated markets * Scouting for partners in Europe who will take full responsibility for registering one or more of the following products [Viz.: Recombinant human G-CSF, rIFN-alpha 2b, erythropoietin (EPO)] * Marketing tie-ups.